Evidence map›Paper›PMID 42212219›Full record

ArticleIranian journal of basic medical sciences2026

Characterization of exosomes from hypoxia-activated human amniotic membrane mesenchymal stem cells.

Hadiseh Kholgh, Fatemeh Eshghabadi, Hanieh Jafary, Kavosh Zandsalimi, Nazanin Akbari, Azadeh Soltani, Banafsheh Heidari

Abstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hadiseh KholghDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Fatemeh EshghabadiDepartment of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran.
Hanieh JafaryDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Kavosh ZandsalimiDepartment of Medical Laser (MLRC), Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Nazanin AkbariDepartment of Biology, Shahid Beheshti University, Tehran, Iran.
Azadeh SoltaniReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Banafsheh HeidariDepartment of Regenerative Medicine in Wound Healing, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Hypoxia is a physical stimulus that enhances stem cell activities to produce more cellular derivatives, particularly exosomes. Enhancing the quantity and quality of exosomes can improve their therapeutic properties. The study aimed to evaluate the effects of normoxic (22%O Materials and Methods: AM-MSCs were isolated, confirmed, and cultured under normoxic and hypoxic conditions. Exosomes were extracted from AM-MSCs and assessed for morphological characteristics (size/distribution/surface topography), structural properties (aggregation/colloidal particle behavior/surface charge/stability), chemical features (functional groups/ionic interactions), biological capacities (total protein concentration), and biocompatibility (microbiological quality/cytotoxicity/irritation/sensitization). Results: Hypoxia did not adversely affect the stemness potential of AM-MSCs ( Conclusion: Hypoxic preconditioning enhances the yield and physicochemical stability of AM-MSC-derived exosomes, due to their unique composition and functional properties.

Indexed as

Amniotic membraneBiocompatibilityExosomesExtracellular vesiclesHypoxiaMesenchymal stem cells

Identifiers

PMID42212219
PMCPMC13213442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.